Developing multiple high‐throughput GLP methods for an investigational drug candidate in various matrices within a 96‐well plate
Authors:
- 22 November 2006
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 20 (24) , 3755-3760
Abstract
In early pharmaceutical product development, an investigational drug candidate is typically dosed to various species for toxicological and pharmacokinetic studies. Most of these studies require multiple analytical methods that have to be validated with good laboratory practice (GLP) prior to the application in regulated studies. Usually, these analytical methods are developed in either a serial or parallel approach. For either approach, the development of multiple analytical methods takes tremendous work from scientists and instruments, and thus is not cost‐effective. In this respect, a new strategy has been developed for simultaneous GLP method development using liquid chromatographic separation and tandem mass spectrometric detection. This high‐throughput approach allows system suitability, carryover, calibration curve, accuracy, precision, matrix effect and selectivity to be evaluated in one 96‐well plate. The strategy has been successfully implemented for multiple investigational drug candidates at Abbott Laboratories. The methods developed with this strategy are accurate, precise, selective, robust and matrix‐independent. As an example, ABT‐279 was used to demonstrate the feasibility of this strategy. Copyright © 2006 John Wiley & Sons, Ltd.Keywords
This publication has 13 references indexed in Scilit:
- A high‐throughput liquid chromatography/tandem mass spectrometry method for simultaneous quantification of a hydrophobic drug candidate and its hydrophilic metabolite in human urine with a fully automated liquid/liquid extractionRapid Communications in Mass Spectrometry, 2006
- Method development and validation for zotarolimus concentration determination in stented swine arteries by liquid chromatography/tandem mass spectrometry detectionRapid Communications in Mass Spectrometry, 2006
- Discovery of 2-[4-{{2-(2S,5R)-2-Cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl]amino]- 4-methyl-1-piperidinyl]-4-pyridinecarboxylic Acid (ABT-279): A Very Potent, Selective, Effective, and Well-Tolerated Inhibitor of Dipeptidyl Peptidase-IV, Useful for the Treatment of DiabetesJournal of Medicinal Chemistry, 2006
- Mechanistic investigation of ionization suppression in electrospray ionizationJournal of the American Society for Mass Spectrometry, 2000
- High-throughput quantitative bioanalysis by LC/MS/MSBiomedical Chromatography, 2000
- LC/MS applications in drug developmentMass Spectrometry Reviews, 1999
- Factors affecting electrospray ionization of effluents containing trifluoroacetic acid for high-performance liquid chromatography/mass spectrometryAnalytical Chemistry, 1993
- Determination of L-654,066, a new 5α-reductase inhibitor in plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometryJournal of Mass Spectrometry, 1992
- Atmospheric pressure ionization mass spectrometry. Detection for the separation sciences.Analytical Chemistry, 1990
- High-speed liquid chromatography/tandem mass spectrometry for the determination of drugs in biological samplesAnalytical Chemistry, 1986